Compare Enzyme (MLN) vs Unibase (UB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Unibase — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Unibase trades at Rp2,324 (market cap Rp5,88T, Rp121,42M 24h volume). The key difference: Unibase is far larger — about 43838.1× Enzyme's market cap, and Unibase's supply is capped (2,5B / 10B UB (25%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Unibase for 3 Days on average.
| MLN | UB | |
|---|---|---|
Market Cap | Rp134,13M | Rp5,88T |
Volume (24h) | Rp104,56M | Rp121,42M |
Circulating Supply | 3,3M MLN | 2,5B / 10B UB (25%) |
Typical Hold Time | 29 Days | 3 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Unibase (UB) trades at Rp2,326 with a market cap of Rp5.88 trillion, showing neutral technical signals overall. The asset is in a consolidation phase near pivot point Rp2,387, with RSI indicating potential oversold conditions. With only 25% of max supply circulating, tokenomics suggest controlled inflation. No major protocol updates or ecosystem news are reported recently.
Outlook is cautious-neutral; key opportunity lies in low RSI hinting at buying potential, but risks include low liquidity and high volatility. Investors should monitor support at Rp2,263 and resistance at Rp2,533 for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Unibase
Unibase is a decentralized AI infrastructure protocol that provides autonomous agents with persistent memory, interoperability, and self-evolution capabilities. It addresses agent statelessness and data silos by providing a decentralized memory layer that combines verifiable storage, cross-agent communication, and high-speed data availability. UB is used for protocol fees, governance, staking, and knowledge-based rewards.
Read more on UB →
